GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
G

Genomictree 228760.KQ · KRW

Health Care · KOSDAQ · 🇰🇷 South Korea

Compare

8,840

+0.45%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in KRW, from our data supplier.

FY2025

Revenue

₩3.76bn

FY2015FY2025

Net income

−₩8.99bn

FY2015FY2025

Free cash flow

−₩12.94bn

FY2015FY2025

Shareholders' equity

₩115.07bn

FY2015FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016FY2015
Revenue₩3.76bn₩2.36bn₩3.42bn₩29.87bn₩5.14bn₩1.24bn₩266.3m₩453.6m₩548.3m₩1.05bn
Research and development₩3.79bn₩4.94bn₩4.37bn₩5.45bn₩2.81bn₩3.51bn₩1.98bn₩880.7m₩389.1m₩380.1m
Operating income−₩11.30bn−₩15.31bn−₩12.75bn₩4.28bn−₩9.86bn−₩12.41bn−₩12.34bn−₩2.01bn−₩1.29bn−₩726.6m
Net income−₩8.99bn−₩10.24bn−₩8.76bn−₩6.63bn−₩11.42bn−₩11.80bn−₩9.60bn−₩2.11bn−₩2.06bn−₩1.23bn
Diluted earnings per share-366.37-426.94-370.52-321.17-562.02-590.16-671.13-147.76-164.87-111.67

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016FY2015
Total assets₩120.76bn₩130.68bn₩132.84bn₩162.91bn₩177.15bn₩117.90bn—₩10.39bn₩5.50bn₩6.73bn
Cash and short-term investments—₩96.08bn₩86.15bn₩114.61bn———₩6.42bn₩1.98bn₩2.85bn
Total liabilities₩5.45bn₩6.36bn₩7.81bn₩55.86bn₩62.05bn₩22.64bn—₩2.09bn₩2.00bn₩7.12bn
Debt—₩2.08bn₩1.83bn₩29.18bn₩38.46bn₩11.55bn₩1.20bn₩506.0m₩500.0m₩5.63bn
Shareholders' equity₩115.07bn₩123.88bn₩124.74bn₩107.05bn₩115.10bn₩95.26bn—₩8.30bn₩3.50bn−₩389.0m
Shares outstanding25m24m24m21m20m20m14m14m13m—

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016FY2015
Cash from operations−₩10.19bn−₩13.63bn−₩10.88bn₩4.29bn−₩7.63bn−₩10.19bn−₩8.77bn−₩1.84bn−₩669.2m−₩697.3m
Capital spending−₩2.75bn−₩2.55bn−₩288.4m−₩1.82bn−₩11.83bn−₩2.68bn−₩2.24bn−₩703.6m−₩223.9m−₩315.6m
Free cash flow−₩12.94bn−₩16.19bn−₩11.17bn₩2.46bn−₩19.46bn−₩12.87bn−₩11.01bn−₩2.54bn−₩893.1m−₩1.01bn

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
Revenue₩842.3m₩381.6m₩825.6m₩896.8m₩1.72bn₩316.5m₩824.5m₩693.4m
Operating income−₩2.64bn−₩3.03bn−₩2.62bn−₩3.44bn−₩1.51bn−₩3.73bn−₩3.65bn−₩3.89bn
Net income−₩2.42bn−₩1.95bn−₩1.94bn−₩2.72bn−₩1.41bn−₩2.91bn−₩1.72bn−₩3.06bn
Diluted earnings per share-98.53-79.49-79.10-113.27-58.88-121.36-71.86-127.35
Cash from operations−₩1.47bn−₩3.45bn−₩3.21bn−₩2.42bn−₩1.55bn−₩3.00bn−₩13.63bn−₩8.94bn
Capital spending−₩1.72bn−₩102.0m−₩62.0m−₩104.0m——−₩2.55bn−₩2.48bn
Free cash flow−₩3.19bn−₩3.55bn−₩3.27bn−₩2.52bn——−₩16.18bn−₩11.42bn
Total assets₩124.41bn₩125.97bn₩120.76bn₩122.89bn₩123.52bn₩127.98bn₩130.68bn₩132.46bn
Cash and short-term investments—————₩88.99bn₩96.08bn₩91.22bn
Debt—————₩50.0m₩60.0m₩69.7m
Shareholders' equity₩121.64bn₩123.17bn₩115.07bn₩115.73bn₩117.02bn₩121.20bn₩123.88bn₩124.10bn

Financial ratios

Data as of 31 Aug 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-300.5%-648.2%-372.9%14.3%-191.7%-1001.6%
Net margin-239.0%-433.6%-256.2%-22.2%-222.3%-952.1%
Return on equity-7.8%-8.3%-7.0%-6.2%-9.9%-12.4%
Return on assets-7.4%-7.8%-6.6%-4.1%-6.4%-10.0%
Revenue growth59.2%-30.9%-88.6%481.1%314.9%365.2%
Earnings growth-12.3%17.0%32.1%-42.0%-3.1%22.9%
Current ratio17.75x20.56x18.06x2.21x62.71x25.75x
Debt to equity—0.00x0.00x0.00x0.32x0.11x
Equity ratio95.3%94.8%93.9%65.7%65.0%80.8%
Interest coverage-33.42x-51.97x-6.20x0.80x-2.14x-7.44x
R&D as a share of sales100.7%209.2%127.7%18.2%54.7%283.3%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue-49.9%24.9%13.6%
Operating income—-1.9%31.6%
Net income10.7%-5.3%22.0%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin-434.7%-89.0%-125.2%—
Net margin-314.1%-87.8%-126.3%—

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2017FY2016
Price to earnings-74.9-47.9-55.6-27.4-23.7-24.8-34.9-47.4-27.3
Price to sales179.1207.7142.46.152.6236.3—220.7102.6

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 2-for-1 split · 14 Sept 2018
  • 3-for-1 split · 9 Nov 2017

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.